{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T14:35:18Z","timestamp":1788014118634,"version":"build-2784847793"},"reference-count":110,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iLIVER"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.iliver.2024.100124","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T23:11:21Z","timestamp":1727737881000},"page":"100124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Arginine methylation modification in the malignant progression of benign and malignant liver diseases"],"prefix":"10.1016","volume":"3","author":[{"given":"Jie-Zuo","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei-Ning","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dang-Chi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Rong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.iliver.2024.100124_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/hepr.12594","article-title":"Molecular basis of alcoholic fatty liver disease: from incidence to treatment","volume":"46","author":"L\u00edvero","year":"2016","journal-title":"Hepatol Res"},{"issue":"10290","key":"10.1016\/j.iliver.2024.100124_bib2","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.iliver.2024.100124_bib3","doi-asserted-by":"crossref","first-page":"E93","DOI":"10.1097\/HEP.0000000000000696","article-title":"Reply: a multi-society Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Lazarus","year":"2024","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.iliver.2024.100124_bib4","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A\u00a0multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J\u00a0Hepatol"},{"issue":"14","key":"10.1016\/j.iliver.2024.100124_bib5","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3748\/wjg.v28.i14.1405","article-title":"Viral hepatitis: past, present, and future","volume":"28","author":"Odenwald","year":"2022","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.iliver.2024.100124_bib6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ijid.2022.06.017","article-title":"Trends in the disease burden of HBV and HCV infection in China from 1990\u20132019","volume":"122","author":"Yue","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.iliver.2024.100124_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12929-022-00818-x","article-title":"Post-translational modifications on the retinoblastoma protein","volume":"29","author":"Zhou","year":"2022","journal-title":"J\u00a0Biomed Sci"},{"issue":"1","key":"10.1016\/j.iliver.2024.100124_bib8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41392-023-01439-y","article-title":"Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct Targeted Ther"},{"issue":"10","key":"10.1016\/j.iliver.2024.100124_bib9","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.metabol.2004.05.008","article-title":"Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3 beta on a muscle-specific promoter","volume":"53","author":"Pearce","year":"2004","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.iliver.2024.100124_bib10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41580-018-0076-0","article-title":"Integrative regulation of physiology by histone deacetylase 3","volume":"20","author":"Emmett","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.iliver.2024.100124_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molcel.2016.11.003","article-title":"Arginine methylation: the coming of age","volume":"65","author":"Blanc","year":"2017","journal-title":"Mol Cell"},{"issue":"10","key":"10.1016\/j.iliver.2024.100124_bib12","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41580-019-0155-x","article-title":"The regulation, functions and clinical relevance of arginine methylation","volume":"20","author":"Guccione","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"13","key":"10.1016\/j.iliver.2024.100124_bib13","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00018-009-0010-x","article-title":"The protein arginine methyltransferase family: an update about function, new perspectives and the physiological role in humans","volume":"66","author":"Wolf","year":"2009","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"10.1016\/j.iliver.2024.100124_bib14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41573-021-00159-8","article-title":"Protein arginine methylation: from enigmatic functions to therapeutic targeting","volume":"20","author":"Wu","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10.1016\/j.iliver.2024.100124_bib15","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202000683R","article-title":"CDKN2A deregulation in fatty liver disease and its accelerative role in the process of lipogenesis","volume":"35","author":"Zhang","year":"2021","journal-title":"Faseb J"},{"issue":"8","key":"10.1016\/j.iliver.2024.100124_bib16","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.2337\/db20-1050","article-title":"Depletion of Prmt1 in adipocytes impairs glucose homeostasis in diet-induced obesity","volume":"70","author":"Choi","year":"2021","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.iliver.2024.100124_bib17","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jhep.2014.06.032","article-title":"Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1\u03b1 regulation in vitro and in vivo","volume":"61","author":"Park","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.iliver.2024.100124_bib18","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00424-013-1339-4","article-title":"Nutritional models of foetal programming and nutrigenomic and epigenomic dysregulations of fatty acid metabolism in the liver and heart","volume":"466","author":"Gu\u00e9ant","year":"2014","journal-title":"Pfl\u00fcgers Archiv"},{"issue":"7441","key":"10.1016\/j.iliver.2024.100124_bib19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nature11966","article-title":"Multidomain integration in the structure of the HNF-4\u03b1 nuclear receptor complex","volume":"495","author":"Chandra","year":"2013","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.iliver.2024.100124_bib20","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.7150\/thno.63824","article-title":"Hepatic PRMT1 ameliorates diet-induced hepatic steatosis via induction of PGC1\u03b1","volume":"12","author":"Xu","year":"2022","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.iliver.2024.100124_bib21","doi-asserted-by":"crossref","first-page":"14863","DOI":"10.1096\/fj.202001061R","article-title":"A\u00a0critical role for hepatic protein arginine methyltransferase 1 isoform 2 in glycemic control","volume":"34","author":"Ma","year":"2020","journal-title":"Faseb J"},{"issue":"9","key":"10.1016\/j.iliver.2024.100124_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102309","article-title":"Protein arginine methyltransferase PRMT1 promotes adipogenesis by modulating transcription factors C\/EBP\u03b2 and PPAR\u03b3","volume":"298","author":"Zhu","year":"2022","journal-title":"J\u00a0Biol Chem"},{"issue":"17","key":"10.1016\/j.iliver.2024.100124_bib23","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.1074\/jbc.M117.778761","article-title":"Protein arginine methyltransferase 1 modulates innate immune responses through regulation of peroxisome proliferator-activated receptor \u03b3-dependent macrophage differentiation","volume":"292","author":"Tikhanovich","year":"2017","journal-title":"J\u00a0Biol Chem"},{"issue":"8","key":"10.1016\/j.iliver.2024.100124_bib24","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/CIRCRESAHA.110.225326","article-title":"Disruption of protein arginine N-methyltransferase 2 regulates leptin signaling and produces leanness in vivo through loss of STAT3 methylation","volume":"107","author":"Iwasaki","year":"2010","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.iliver.2024.100124_bib25","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.bbadis.2019.02.012","article-title":"Inhibition of PRMT3 activity reduces hepatic steatosis without altering atherosclerosis susceptibility in apoE knockout mice","volume":"1865","author":"Hoekstra","year":"2019","journal-title":"Biochim Biophys Acta, Mol Basis Dis"},{"issue":"1","key":"10.1016\/j.iliver.2024.100124_bib26","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41598-021-04524-w","article-title":"PRMT3 inhibitor SGC707 reduces triglyceride levels and induces pruritus in Western-type diet-fed LDL receptor knockout mice","volume":"12","author":"de Jong","year":"2022","journal-title":"Sci Rep"},{"issue":"15","key":"10.1016\/j.iliver.2024.100124_bib27","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1111\/bph.14361","article-title":"Inhibition of protein arginine methyltransferase 3 activity selectively impairs liver X receptor-driven transcription of hepatic lipogenic genes in vivo","volume":"175","author":"Nahon","year":"2018","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.iliver.2024.100124_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2337\/db13-1394","article-title":"PRMT3 regulates hepatic lipogenesis through direct interaction with LXR\u03b1","volume":"64","author":"Kim","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.iliver.2024.100124_bib29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.atherosclerosis.2021.11.001","article-title":"PRMT4 inhibitor TP-064 impacts both inflammatory and metabolic processes without changing the susceptibility for early atherosclerotic lesions in male apolipoprotein E knockout mice","volume":"338","author":"Zhang","year":"2021","journal-title":"Atherosclerosis"},{"issue":"28","key":"10.1016\/j.iliver.2024.100124_bib30","doi-asserted-by":"crossref","first-page":"10884","DOI":"10.1074\/jbc.RA118.002377","article-title":"Inhibition of protein arginine methyltransferase 5 enhances hepatic mitochondrial biogenesis","volume":"293","author":"Huang","year":"2018","journal-title":"J\u00a0Biol Chem"},{"issue":"7","key":"10.1016\/j.iliver.2024.100124_bib31","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/liv.15906","article-title":"Excessive fatty acids activate PRMT5\/MDM2\/Drosha pathway to regulate miRNA biogenesis and lipid metabolism","volume":"44","author":"Hou","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.iliver.2024.100124_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155938","article-title":"Regulation of hepatic lipogenesis by asymmetric arginine methylation","volume":"157","author":"Han","year":"2024","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.iliver.2024.100124_bib33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","article-title":"NAFLD and diabetes mellitus","volume":"14","author":"Tilg","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.iliver.2024.100124_bib34","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/hep.25809","article-title":"Protein arginine methyltransferase 1 regulates hepatic glucose production in a FoxO 1-dependent manner","volume":"56","author":"Choi","year":"2012","journal-title":"Hepatology"},{"issue":"314","key":"10.1016\/j.iliver.2024.100124_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004479","article-title":"Arginine methylation of CRTC2 is critical in the transcriptional control of hepatic glucose metabolism","volume":"7","author":"Han","year":"2014","journal-title":"Sci Signal"},{"issue":"9","key":"10.1016\/j.iliver.2024.100124_bib36","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200238R","article-title":"Inhibition of protein arginine methyltransferase 1\u00a0alleviates liver fibrosis by attenuating the activation of hepatic stellate cells in\u00a0mice","volume":"36","author":"Yan","year":"2022","journal-title":"Faseb J"},{"issue":"4","key":"10.1016\/j.iliver.2024.100124_bib37","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.bbrc.2015.11.055","article-title":"Characterization and sub-cellular localization of GalNAc-binding proteins isolated from human hepatic stellate cells","volume":"468","author":"Zhong","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"10.1016\/j.iliver.2024.100124_bib38","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1016\/j.celrep.2020.02.063","article-title":"OXR1A, a coactivator of PRMT5 regulating histone arginine methylation","volume":"30","author":"Yang","year":"2020","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.iliver.2024.100124_bib39","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.21491","article-title":"Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis","volume":"45","author":"Mookerjee","year":"2007","journal-title":"Hepatology"},{"issue":"Pt B","key":"10.1016\/j.iliver.2024.100124_bib40","article-title":"Silencing miR-181b-5p upregulates PIAS1 to repress oxidative stress and inflammatory response in rats with alcoholic fatty liver disease through inhibiting PRMT1","volume":"101","author":"Wang","year":"2021","journal-title":"Int Immunopharm"},{"issue":"3","key":"10.1016\/j.iliver.2024.100124_bib41","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/hep.29587","article-title":"Protein arginine methyl transferase 1- and Jumonji C domain-containing protein 6-dependent arginine methylation regulate hepatocyte nuclear factor 4 alpha expression and hepatocyte proliferation in mice","volume":"67","author":"Zhao","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.iliver.2024.100124_bib42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3727\/105221618X15372014086197","article-title":"PRMT1-dependent macrophage IL-6 production is required for alcohol-induced HCC progression","volume":"19","author":"Zhao","year":"2019","journal-title":"Gene Expr"},{"key":"10.1016\/j.iliver.2024.100124_bib43","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.coviro.2018.01.007","article-title":"Role of HBx in hepatitis B virus persistence and its therapeutic implications","volume":"30","author":"Slagle","year":"2018","journal-title":"Curr Opin Virol"},{"issue":"8","key":"10.1016\/j.iliver.2024.100124_bib44","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1128\/JVI.02574-12","article-title":"Methyltransferase PRMT1 is a binding partner of HBx and a negative regulator of hepatitis B virus transcription","volume":"87","author":"Benhenda","year":"2013","journal-title":"J\u00a0Virol"},{"issue":"2","key":"10.1016\/j.iliver.2024.100124_bib45","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/hep.29133","article-title":"PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation","volume":"66","author":"Zhang","year":"2017","journal-title":"Hepatology"},{"issue":"17","key":"10.1016\/j.iliver.2024.100124_bib46","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.7150\/thno.57531","article-title":"HBx represses WDR77 to enhance HBV replication by DDB1-mediated WDR77 degradation in the liver","volume":"11","author":"Yuan","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.iliver.2024.100124_bib47","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1186\/s12967-023-04408-9","article-title":"Arginine methylation of HSPA8 by PRMT9 inhibits ferroptosis to accelerate hepatitis B virus-associated hepatocellular carcinoma progression","volume":"21","author":"Deng","year":"2023","journal-title":"J\u00a0Transl Med"},{"issue":"3","key":"10.1016\/j.iliver.2024.100124_bib48","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/hep.23388","article-title":"Hepatitis C virus-induced up-regulation of protein phosphatase 2A inhibits histone modification and DNA damage repair","volume":"51","author":"Duong","year":"2010","journal-title":"Hepatology"},{"issue":"24","key":"10.1016\/j.iliver.2024.100124_bib49","doi-asserted-by":"crossref","first-page":"15342","DOI":"10.1128\/JVI.79.24.15342-15350.2005","article-title":"Upregulation of protein phosphatase 2Ac by hepatitis C virus modulates NS3 helicase activity through inhibition of protein arginine methyltransferase 1","volume":"79","author":"Duong","year":"2005","journal-title":"J\u00a0Virol"},{"issue":"1","key":"10.1016\/j.iliver.2024.100124_bib50","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1128\/JVI.01292-06","article-title":"Inhibition of alpha interferon signaling by hepatitis B virus","volume":"81","author":"Christen","year":"2007","journal-title":"J\u00a0Virol"},{"issue":"47","key":"10.1016\/j.iliver.2024.100124_bib51","doi-asserted-by":"crossref","first-page":"9665","DOI":"10.1039\/C4OB01591F","article-title":"Virtual screening and biological evaluation of novel small molecular inhibitors against protein arginine methyltransferase 1 (PRMT1)","volume":"12","author":"Xie","year":"2014","journal-title":"Org Biomol Chem"},{"issue":"2","key":"10.1016\/j.iliver.2024.100124_bib52","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317691419","article-title":"Protein arginine N-methyltransferase 1 promotes the proliferation and metastasis of hepatocellular carcinoma cells","volume":"39","author":"Gou","year":"2017","journal-title":"Tumour Biol"},{"issue":"4","key":"10.1016\/j.iliver.2024.100124_bib53","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.bbrc.2015.06.169","article-title":"MiR-503 suppresses metastasis of hepatocellular carcinoma cell by targeting PRMT1","volume":"464","author":"Li","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"issue":"70","key":"10.1016\/j.iliver.2024.100124_bib54","doi-asserted-by":"crossref","first-page":"115444","DOI":"10.18632\/oncotarget.23296","article-title":"Novel prognostic marker PRMT1 regulates cell growth via downregulation of CDKN1A in HCC","volume":"8","author":"Ryu","year":"2017","journal-title":"Oncotarget"},{"issue":"14","key":"10.1016\/j.iliver.2024.100124_bib55","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1158\/0008-5472.CAN-21-0436","article-title":"Epigenetic induction of mitochondrial fission is required for maintenance of liver cancer-initiating cells","volume":"81","author":"Tang","year":"2021","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.iliver.2024.100124_bib56","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/s41467-023-36708-5","article-title":"PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma","volume":"14","author":"Wang","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.iliver.2024.100124_bib57","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/JHC.S443130","article-title":"PRMT1 integrates immune microenvironment and fatty acid metabolism response in progression of hepatocellular carcinoma","volume":"11","author":"Yan","year":"2024","journal-title":"J\u00a0Hepatocell Carcinoma"},{"issue":"6","key":"10.1016\/j.iliver.2024.100124_bib58","doi-asserted-by":"crossref","first-page":"918","DOI":"10.4149\/neo_2018_181226N999","article-title":"Protein arginine methyltransferase 1 promotes epithelial-mesenchymal transition via TGF-\u03b21\/Smad pathway in hepatic carcinoma cells","volume":"66","author":"Wei","year":"2019","journal-title":"Neoplasma"},{"issue":"4","key":"10.1016\/j.iliver.2024.100124_bib59","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1159\/000490983","article-title":"PRMT1 promoted HCC growth and metastasis in vitro and in vivo via activating the STAT3 signalling pathway","volume":"47","author":"Zhang","year":"2018","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"10.1016\/j.iliver.2024.100124_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112152","article-title":"PRMT2 accelerates tumorigenesis of hepatocellular carcinoma by activating Bcl 2 via histone H3R8 methylation","volume":"394","author":"Hu","year":"2020","journal-title":"Exp Cell Res"},{"issue":"1","key":"10.1016\/j.iliver.2024.100124_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.686","article-title":"Protein arginine methyltransferase 3 promotes glycolysis and hepatocellular carcinoma growth by enhancing arginine methylation of lactate dehydrogenase A","volume":"12","author":"Lei","year":"2022","journal-title":"Clin Transl Med"},{"issue":"1","key":"10.1016\/j.iliver.2024.100124_bib62","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1038\/s41467-023-37542-5","article-title":"PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer","volume":"14","author":"Shi","year":"2023","journal-title":"Nat Commun"},{"issue":"15","key":"10.1016\/j.iliver.2024.100124_bib63","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.7150\/ijms.62467","article-title":"PRMT4 promotes hepatocellular carcinoma progression by activating AKT\/mTOR signaling and indicates poor prognosis","volume":"18","author":"Du","year":"2021","journal-title":"Int J Med Sci"},{"issue":"4","key":"10.1016\/j.iliver.2024.100124_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112316","article-title":"CDK5-PRMT1-WDR24 signaling cascade promotes mTORC1 signaling and tumor growth","volume":"42","author":"Yin","year":"2023","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.iliver.2024.100124_bib65","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3390\/biology13040216","article-title":"PRMT5 mediated HIF1\u03b1 signaling and ras-related nuclear protein as promising biomarker in hepatocellular carcinoma","volume":"13","author":"Abumustafa","year":"2024","journal-title":"Biology"},{"issue":"2","key":"10.1016\/j.iliver.2024.100124_bib66","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3892\/ijo.2017.3833","article-title":"The protein arginine methyltransferase 5 promotes malignant phenotype of hepatocellular carcinoma cells and is associated with adverse patient outcomes after curative hepatectomy","volume":"50","author":"Shimizu","year":"2017","journal-title":"Int J Oncol"},{"issue":"12","key":"10.1016\/j.iliver.2024.100124_bib67","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrendo.2017.91","article-title":"SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology","volume":"13","author":"Shimano","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"10.1016\/j.iliver.2024.100124_bib68","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1158\/0008-5472.CAN-15-1766","article-title":"Arginine methylation of SREBP1a via PRMT5 promotes de novo lipogenesis and tumor growth","volume":"76","author":"Liu","year":"2016","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.iliver.2024.100124_bib69","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1038\/s41401-021-00841-y","article-title":"PRMT5 confers lipid metabolism reprogramming, tumour growth and metastasis depending on the SIRT7-mediated desuccinylation of PRMT5 K387 in tumours","volume":"43","author":"Yuan","year":"2022","journal-title":"Acta Pharmacol Sin"},{"issue":"44","key":"10.1016\/j.iliver.2024.100124_bib70","doi-asserted-by":"crossref","first-page":"72131","DOI":"10.18632\/oncotarget.12351","article-title":"PRMT5 competitively binds to CDK4 to promote G1-S transition upon glucose induction in hepatocellular carcinoma","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.iliver.2024.100124_bib71","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/cam4.1360","article-title":"PRMT5 promotes cell proliferation by inhibiting BTG2 expression via the ERK signaling pathway in hepatocellular carcinoma","volume":"7","author":"Jiang","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.iliver.2024.100124_bib72","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s12967-015-0721-8","article-title":"Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin","volume":"13","author":"Zhang","year":"2015","journal-title":"J\u00a0Transl Med"},{"issue":"2","key":"10.1016\/j.iliver.2024.100124_bib73","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/carcin\/bgz065","article-title":"Metadherin-PRMT5 complex enhances the metastasis of hepatocellular carcinoma through the WNT-\u03b2-catenin signaling pathway","volume":"41","author":"Zhu","year":"2020","journal-title":"Carcinogenesis"},{"issue":"5","key":"10.1016\/j.iliver.2024.100124_bib74","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/cas.16139","article-title":"SMYD4 monomethylates PRMT5 and forms a positive feedback loop to promote hepatocellular carcinoma progression","volume":"115","author":"Zhou","year":"2024","journal-title":"Cancer Sci"},{"issue":"3","key":"10.1016\/j.iliver.2024.100124_bib75","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.celrep.2018.09.053","article-title":"PRMT6 regulates RAS\/RAF binding and MEK\/ERK-mediated cancer stemness activities in hepatocellular carcinoma through CRAF methylation","volume":"25","author":"Chan","year":"2018","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.iliver.2024.100124_bib76","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/hep.30923","article-title":"CRAF methylation by PRMT6 regulates aerobic glycolysis-driven hepatocarcinogenesis via ERK-dependent PKM2 nuclear relocalization and activation","volume":"71","author":"Wong","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.iliver.2024.100124_bib77","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.canlet.2020.11.002","article-title":"PRMT6 deficiency induces autophagy in hostile microenvironments of hepatocellular carcinoma tumors by regulating BAG5-associated HSC70 stability","volume":"501","author":"Che","year":"2021","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.iliver.2024.100124_bib78","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/s41467-022-28861-0","article-title":"An enhancer variant at 16q22.1 predisposes to hepatocellular carcinoma via regulating PRMT7 expression","volume":"13","author":"Shen","year":"2022","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.iliver.2024.100124_bib79","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/cas.13598","article-title":"PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K\/Akt\/GSK-3\u03b2\/Snail signaling","volume":"109","author":"Jiang","year":"2018","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.iliver.2024.100124_bib80","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12885-023-11703-7","article-title":"A\u00a0hsa_circ_001726 axis regulated by E2F6 contributes to metastasis of hepatocellular carcinoma","volume":"24","author":"Ai","year":"2024","journal-title":"BMC Cancer"},{"issue":"15","key":"10.1016\/j.iliver.2024.100124_bib81","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.3390\/cancers15153999","article-title":"Alternative splicing events and their clinical significance in colorectal cancer: targeted therapeutic opportunities","volume":"15","author":"Manabile","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.iliver.2024.100124_bib82","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1042\/BJ20101793","article-title":"Interleukin enhancer-binding factor 3 functions as a liver receptor homologue-1 co-activator in synergy with the nuclear receptor co-activators PRMT1 and PGC-1\u03b1","volume":"437","author":"Ohno","year":"2011","journal-title":"Biochem J"},{"issue":"11","key":"10.1016\/j.iliver.2024.100124_bib83","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.molmed.2019.05.007","article-title":"PRMTs and arginine methylation: cancer's best-kept secret?","volume":"25","author":"Jarrold","year":"2019","journal-title":"Trends Mol Med"},{"issue":"11","key":"10.1016\/j.iliver.2024.100124_bib84","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1158\/2159-8290.CD-23-0669","article-title":"MRTX1719 is an MTA-cooperative PRMT5 inhibitor that exhibits synthetic lethality in preclinical models and patients with MTAP-deleted cancer","volume":"13","author":"Engstrom","year":"2023","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.iliver.2024.100124_bib85","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ccell.2019.05.014","article-title":"Anti-tumor activity of the type I PRMT inhibitor, GSK3368715,synergizes with PRMT5 inhibition through MTAP loss","volume":"36","author":"Fedoriw","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.iliver.2024.100124_bib86","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41416-023-02276-0","article-title":"Phase 1 study of GSK3368715,a type I PRMT inhibitor, in patients with advanced solid tumors","volume":"129","author":"El-Khoueiry","year":"2023","journal-title":"Br J Cancer"},{"issue":"23","key":"10.1016\/j.iliver.2024.100124_bib87","doi-asserted-by":"crossref","first-page":"23892","DOI":"10.1074\/jbc.M401853200","article-title":"Small molecule regulators of protein arginine methyltransferases","volume":"279","author":"Cheng","year":"2004","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.iliver.2024.100124_bib88","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/10717544.2020.1745327","article-title":"Developing protein arginine methyltransferase 1 (PRMT1) inhibitor TC-E-5003 as an antitumor drug using INEI drug delivery systems","volume":"27","author":"Zhang","year":"2020","journal-title":"Drug Deliv"},{"issue":"1","key":"10.1016\/j.iliver.2024.100124_bib89","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/cmdc.200800301","article-title":"Virtual screening and biological characterization of novel histone arginine methyltransferase PRMT1 inhibitors","volume":"4","author":"Heinke","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.iliver.2024.100124_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117436","article-title":"Discovery of 2, 4-diphenyl-substituted thiazole derivatives as PRMT1 inhibitors and investigation of their anti-cervical cancer effects","volume":"92","author":"Zhao","year":"2023","journal-title":"Bioorg Med Chem"},{"issue":"3","key":"10.1016\/j.iliver.2024.100124_bib91","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1021\/acschembio.5b00839","article-title":"A\u00a0potent, selective, and cell-active inhibitor of human type I protein arginine methyltransferases","volume":"11","author":"Eram","year":"2016","journal-title":"ACS Chem Biol"},{"issue":"6","key":"10.1016\/j.iliver.2024.100124_bib92","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3390\/biom11060854","article-title":"A\u00a0pan-inhibitor for protein arginine methyltransferase family enzymes","volume":"11","author":"Iyamu","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.iliver.2024.100124_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105728","article-title":"The antidepressant effects of protein arginine methyltransferase 2 involve neuroinflammation","volume":"176","author":"Liu","year":"2024","journal-title":"Neurochem Int"},{"issue":"17","key":"10.1016\/j.iliver.2024.100124_bib94","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1002\/anie.201412154","article-title":"A\u00a0potent, selective and cell-active allosteric inhibitor of protein arginine methyltransferase 3 (PRMT3)","volume":"54","author":"\u00dcmit Kaniskan","year":"2015","journal-title":"Angew Chem Int Ed"},{"issue":"26","key":"10.1016\/j.iliver.2024.100124_bib95","doi-asserted-by":"crossref","first-page":"18480","DOI":"10.18632\/oncotarget.24883","article-title":"TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma","volume":"9","author":"Nakayama","year":"2018","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.iliver.2024.100124_bib96","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1016\/j.apsb.2020.10.013","article-title":"Discovery of a potent and dual-selective bisubstrate inhibitor for protein arginine methyltransferase 4\/5","volume":"11","author":"Al-Hamashi","year":"2021","journal-title":"Acta Pharm Sin B"},{"issue":"19","key":"10.1016\/j.iliver.2024.100124_bib97","doi-asserted-by":"crossref","first-page":"9124","DOI":"10.1021\/acs.jmedchem.6b01033","article-title":"Discovery of a potent, selective, and cell-active dual inhibitor of protein arginine methyltransferase 4 and protein arginine methyltransferase 6","volume":"59","author":"Shen","year":"2016","journal-title":"J\u00a0Med Chem"},{"issue":"1","key":"10.1016\/j.iliver.2024.100124_bib98","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-18446-z","article-title":"Identification of a CARM1 inhibitor with potent in vitro and in vivo activity in preclinical models of multiple myeloma","volume":"7","author":"Drew","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.iliver.2024.100124_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116288","article-title":"Structure-based discovery of potent CARM1 inhibitors for colorectal cancer therapy","volume":"269","author":"Liu","year":"2024","journal-title":"Eur J Med Chem"},{"issue":"6","key":"10.1016\/j.iliver.2024.100124_bib100","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nchembio.1810","article-title":"A\u00a0selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models","volume":"11","author":"Chan-Penebre","year":"2015","journal-title":"Nat Chem Biol"},{"issue":"7","key":"10.1016\/j.iliver.2024.100124_bib101","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1021\/acsmedchemlett.8b00014","article-title":"LLY-283, a potent and selective inhibitor of arginine methyltransferase 5, PRMT5, with antitumor activity","volume":"9","author":"Bonday","year":"2018","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.iliver.2024.100124_bib102","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ebiom.2019.05.011","article-title":"A\u00a0novel small-molecule antagonizes PRMT5-mediated KLF4 methylation for targeted therapy","volume":"44","author":"Zhou","year":"2019","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/j.iliver.2024.100124_bib103","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1038\/s41418-021-00793-0","article-title":"Arginine methyltransferase PRMT5 methylates and stabilizes KLF5 via decreasing its phosphorylation and ubiquitination to promote basal-like breast cancer","volume":"28","author":"Wang","year":"2021","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.iliver.2024.100124_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115032","article-title":"Design, synthesis and evaluation of antitumor activity of selective PRMT6 inhibitors","volume":"247","author":"Zhang","year":"2023","journal-title":"Eur J Med Chem"},{"issue":"6","key":"10.1016\/j.iliver.2024.100124_bib105","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1021\/acsmedchemlett.5b00071","article-title":"Aryl pyrazoles as potent inhibitors of arginine methyltransferases: identification of the first PRMT6 tool compound","volume":"6","author":"Mitchell","year":"2015","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.iliver.2024.100124_bib106","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1038\/s41467-020-16271-z","article-title":"Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response","volume":"11","author":"Szewczyk","year":"2020","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.iliver.2024.100124_bib107","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cmet.2022.04.004","article-title":"Loss of PRMT7 reprograms Glycine metabolism to selectively eradicate leukemia stem cells in CML","volume":"34","author":"Liu","year":"2022","journal-title":"Cell Metabol"},{"issue":"21","key":"10.1016\/j.iliver.2024.100124_bib108","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1016\/j.molcel.2021.09.011","article-title":"Cellular pathways influenced by protein arginine methylation: implications for cancer","volume":"81","author":"Xu","year":"2021","journal-title":"Mol Cell"},{"issue":"12","key":"10.1016\/j.iliver.2024.100124_bib109","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/tcr.201800082","article-title":"Mechanisms and inhibitors of histone arginine methylation","volume":"18","author":"Fulton","year":"2018","journal-title":"Chem Rec"},{"issue":"3","key":"10.1016\/j.iliver.2024.100124_bib110","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1517\/13543784.2016.1144747","article-title":"Small molecule inhibitors of protein arginine methyltransferases","volume":"25","author":"Hu","year":"2016","journal-title":"Expet Opin Invest Drugs"}],"container-title":["iLIVER"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772947824000495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772947824000495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T17:07:53Z","timestamp":1734109673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772947824000495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":110,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2772947824000495"],"URL":"https:\/\/doi.org\/10.1016\/j.iliver.2024.100124","relation":{},"ISSN":["2772-9478"],"issn-type":[{"value":"2772-9478","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Arginine methylation modification in the malignant progression of benign and malignant liver diseases","name":"articletitle","label":"Article Title"},{"value":"iLIVER","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iliver.2024.100124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of Tsinghua University Press.","name":"copyright","label":"Copyright"}],"article-number":"100124"}}